📰 Ankur Vaid News
Ankur Vaid News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ankur Vaid. Real-time updates on events, politics, business and more.
August 23, 2023
So we expect to do better than what we have done historically, which was a CAGR growth of 18%. And this as economies of scale would kick in once a new site starts ramping up, we see our margin profiling being better than what it has been historically, which has been in the range of around 40%.
August 17, 2023
Concord Biotechs grey market premium fell to 13-15 percent from 28 percent in the beginning of current month
August 8, 2023
Concord Biotech IPO | The main objective of the issue is to give a exit to Helix Investment Holdings which has 20 percent stake in the company.
August 3, 2023
Concord Biotech IPO | The issue comprises only an offer for sale (OFS) by Helix Investment Holdings Pte Limited, which is backed by Quadria Capital Fund LP, a healthcare-focused private equity fund in Asia.
July 26, 2023
According to the draft papers, healthcare-focused Asian private equity firm Quadria Capital also picked up a 20 percent stake in Concord Biotech in 2016